Tools

LEADER 04385cam 22005774a 4500

001 ocm60028983;

003 OCoLC;

005 20141211185148.0;

008 050428s2005 enka b 001 0 eng ;

010 a| 2005012018;

016 7 a| 1012638882| DNLM;

020 a| 0521854962;

020 a| 9780521854962;

029 1 a| NLMb| 101263888;

035 a| (Sirsi) o60028983;

035 a| (OCoLC)60028983;

042 a| pcc;

049 a| EREE;

050 00 a| HD9665.5b| .E85 2005;

060 00 a| 2005 O-341;

060 10 a| QV 736b| E848 2005;

082 00 a| 338.4/761512| 22;

245 00 a| Ethics and the pharmaceutical industry /c| edited by Michael A. Santoro, Thomas M. Gorrie.;

260 a| Cambridge ;a| New York, NY :b| Cambridge University Press,c| 2005.;

300 a| xxxiv, 492 pages :b| illustrations ;c| 24 cm;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

504 a| Includes bibliographical references and index.;

505 0 a| Drug research: between ethical demands and economic constraints / Jürgen Drews -- Emerging international norms for clinical testing: good clinical trial practice / Juhana E. Idänpään-Heikkilä, Sev Fluss -- The regulatory and ethical challenges of pediatric research / M. Dianne Murphy, Sara F. Goldkind -- Including children in research: participation or exploitation? / Robert M. Nelson -- Racial and ethnic inclusiveness in clinical trials / Valentine J. Burroughs -- The rights of patients to participate in clinical research / Glenna M. Crooks -- How should government regulate stem-cell research? views from a scientist-legislator / Rush Holt -- Ethics and prescribing: the clinician's perspective / Charles L. Bardes -- The regulation of prescription drug promotion / Thomas Abrams --;

505 0 a| Direct-to-consumer advertising of prescription drugs: a policy dilemma / Meredith B. Rosenthal, Julie M. Donohue -- Off-label communications and prescription drugs / Schott D. Danzis -- The need for better health information: advancing the informed patient in Europe / Don E. Detmer, Peter Singleton, Scott C. Ratzan -- Who should get access to which drugs? an ethical template for pharmacy benefits / Norman Daniels, James E. Sabin, J. Russell Teagarden -- The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals / Joel W. Hay -- Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities / Patricia H. Werhande, Michael E. Gorman --;

505 0 a| A future agenda for government-industry relations / William C. Weldon -- AIDS activism and the pharmaceutical industry / Martin Delaney -- The campaign against innovation / Sidney Taurel -- Third world perspectives on global pharmaceutical access / James Thuo Gathii -- The promise of vaccines and the influenza vaccine shortage of 2004: public and private partnerships / Gary R. Noble -- Evolving approaches to healthcare challenges / Thomas M. Gorrie -- Property rights in crisis: managers and rescue / Nien-hê Hsieh -- Blurring the lines: public and private partnerships addressing global health / William H. Foege -- Renegotiating the grand bargain: balancing prices, profits, people, and principles / Edward Greg Koski.;

650 0 a| Pharmaceutical industry.=| ^A3655;

650 0 a| Drugsx| Marketingx| Moral and ethical aspects.=| ^A301163;

650 0 a| Drugsx| Researchx| Moral and ethical aspects.=| ^A47379;

650 0 a| Medical innovationsx| Social aspects.=| ^A7232;

650 0 a| Social responsibility of business.=| ^A285320;

650 0 a| Pharmaceutical industryx| Ethics.=| ^A3655;

650 0 a| Pharmaceutical industryx| Organization and administration.=| ^A3655;

650 0 a| Business ethics.=| ^A17338;

650 22 a| Social Responsibility.=| ^A924208;

650 0 a| Pharmaceutical technologyx| Ethics.=| ^A234566;

700 1 a| Santoro, Michael A.=| ^A449333;

700 1 a| Gorrie, Thomas M.=| ^A628307;

856 41 3| Table of contentsu| http://www.loc.gov/catdir/toc/ecip0511/2005012018.html;

994 a| C0b| ERE;

938 a| Baker & Taylorb| BKTYc| 40.00d| 40.00i| 0521854962n| 0006413194s| active;

596 a| 1;

998 a| 1029163;

999 a| HD9665.5 .E85 2005w| LCc| 1i| 30372013556060d| 10/3/2011e| 9/14/2011f| 3/19/2009g| 1l| JGESm| JOYNERn| 9p| $33.60q| 1r| Ys| Yt| JGESBKu| 3/17/2006x| BOOKz| JSTACKSo| .STAFF. 0;

Ethics and the pharmaceutical industry / edited by Michael A. Santoro, Thomas M. Gorrie.

Other author	Santoro, Michael A.
Other author	Gorrie, Thomas M.
Format	Book
Publication Info	Cambridge ; New York, NY : Cambridge University Press, 2005.
Description	xxxiv, 492 pages : illustrations ; 24 cm
Supplemental Content	Table of contents
Subjects	Pharmaceutical industry. Drugs--Marketing. --Moral and ethical aspects. Drugs--Research. --Moral and ethical aspects. Medical innovations--Social aspects. Social responsibility of business. Pharmaceutical industry--Ethics. Pharmaceutical industry--Organization and administration. Business ethics. Social Responsibility. Pharmaceutical technology--Ethics.

Contents	Drug research: between ethical demands and economic constraints / Jürgen Drews -- Emerging international norms for clinical testing: good clinical trial practice / Juhana E. Idänpään-Heikkilä, Sev Fluss -- The regulatory and ethical challenges of pediatric research / M. Dianne Murphy, Sara F. Goldkind -- Including children in research: participation or exploitation? / Robert M. Nelson -- Racial and ethnic inclusiveness in clinical trials / Valentine J. Burroughs -- The rights of patients to participate in clinical research / Glenna M. Crooks -- How should government regulate stem-cell research? views from a scientist-legislator / Rush Holt -- Ethics and prescribing: the clinician's perspective / Charles L. Bardes -- The regulation of prescription drug promotion / Thomas Abrams --
Contents	Direct-to-consumer advertising of prescription drugs: a policy dilemma / Meredith B. Rosenthal, Julie M. Donohue -- Off-label communications and prescription drugs / Schott D. Danzis -- The need for better health information: advancing the informed patient in Europe / Don E. Detmer, Peter Singleton, Scott C. Ratzan -- Who should get access to which drugs? an ethical template for pharmacy benefits / Norman Daniels, James E. Sabin, J. Russell Teagarden -- The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals / Joel W. Hay -- Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities / Patricia H. Werhande, Michael E. Gorman --
Contents	A future agenda for government-industry relations / William C. Weldon -- AIDS activism and the pharmaceutical industry / Martin Delaney -- The campaign against innovation / Sidney Taurel -- Third world perspectives on global pharmaceutical access / James Thuo Gathii -- The promise of vaccines and the influenza vaccine shortage of 2004: public and private partnerships / Gary R. Noble -- Evolving approaches to healthcare challenges / Thomas M. Gorrie -- Property rights in crisis: managers and rescue / Nien-hê Hsieh -- Blurring the lines: public and private partnerships addressing global health / William H. Foege -- Renegotiating the grand bargain: balancing prices, profits, people, and principles / Edward Greg Koski.
Bibliography note	Includes bibliographical references and index.
LCCN	2005012018
ISBN	0521854962
ISBN	9780521854962

Ethics and the pharmaceutical industry / edited by Michael A. Santoro, Thomas M. Gorrie.

Click here for more information about this title